Brainstorm to announce fourth quarter and fiscal year 2021 financial results and provide a corporate update

New york, march 14, 2022 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today that the company will hold a conference call to update shareholders on financial results for the fourth quarter and year ended december 31, 2021, and provide a corporate update, at 8:00 a.m. eastern time on monday, march 28, 2022.
BCLI Ratings Summary
BCLI Quant Ranking